ERSP Reviews Advertising For Bosom Max

New York, NY – June 14, 2011 – The Electronic Retailing Self-Regulation Program (ERSP) has determined that Total Media Market has not provided adequate support for performance and establishment claims made in direct response advertising for Bosom Max.

ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

The marketer’s advertising came to ERSP’s attention pursuant to its ongoing monitoring program.

Claims at issue in the initial inquiry included:

  • “The  electrostatic  vibrations  of  the  BOSOM  MAX  brassiere  stimulate  breast tissues, help increase the circulation of blood & lymphatic fluid, and increase muscle mass to lift up your breasts and enlarge their size!”
  • “Those vibrations also generate contractions of the pectoral muscles, increasing muscle mass to firm up and lift sagging breasts, and increasing their size.”
  • “…results are quick and permanent.”
  • “Proven with Clinical Studies!”
    • “With its high concentration of phytoestrogens, the Bosom Max cream helps to increase the elasticity and firmness of breast tissues. Those same phytoestrogens can also help reduce the effects of menopause, and may even help to protect against breast cancer.”
    • “Specifically formulated with natural ingredients of potent nourishing and revitalizing qualities, FirmMax is the ideal solution to firm up, lift, and restore a more youthful appearance to yours breasts and gluts.”
    • “Aside from the innovative brassiere, the BOSOM MAX capsules supply the breasts with essential nutrients needed for proper growth, and the BOSOM MAX cream helps to increase elasticity of the skin to avoid stretch marks during the breast enhancement process.”
    • “But with Bosom Max I increased in size from a 34-B to a 34-D!” [Consumer Testimonial]

 

At the outset of the inquiry, Total Media Market removed the claim that Bosom Max was “featured on” news programs and in magazines, and modified the statement on the Bosom Max Website. The marketer also provided evidence to support the claim that “Scientists in Asia studied the reduction of tumors and lumps in women with electrostatic vibrations, and discovered that massages with low-frecuency [sic] stimulation and vibrations to the breasts also produced as a result surprising increase in the size and firmness of breasts in women who wore the vibrations-producing brassiere for a few days.”

Although the marketer provided two studies of a device that simulated the Bosom Max brassiere, ERSP determined that the testing reports submitted by Total Media Market were not sufficient to support claims that the product is clinically proven to perform. In light of the fact that the marketer failed to submit evidence to ERSP that would demonstrate a reasonable basis for the performance and establishment claims communicated by the advertising, ERSP recommended that the marketer modify or discontinue almost of the all performance and establishment claims in its advertising. ERSP also recommended that the marketer discontinue consumer testimonial claims communicating a specific increase in breast size.

 

ERSP forwarded a copy of its determination to the marketer and requested a statement as to whether Total Media Market agreed to discontinue the advertising claims that were the subject of the self-regulatory inquiry; however, the company did not respond to ERSP’s request for a Marketer’s Statement. Accordingly, this matter will be referred to the appropriate governmental agencies for review and possible law enforcement action pursuant to section 3.1(D) of the Electronic Retailing Self Regulation Program Policy & Procedures.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Finds Realtor.com “#1 Site Real Estate Professionals Trust” Claim Supported

New York, NY – November 8, 2024 – In a challenge brought by competitor CoStar Group, the National Advertising Division determined that Move provided a reasonable basis for its claim that Realtor.com is the “#1 site real estate professionals trust.

Read the Decision Summary
Decision

National Advertising Division Recommends Verizon Discontinue or Modify Certain Claims for Satellite-Supported Texting Services

New York, NY – November 7, 2024 – In a Fast-Track SWIFT challenge brought by T-Mobile, the National Advertising Division recommended that Verizon either discontinue certain claims about satellite-supported texting services in remote locations or modify them to disclose the necessary conditions for Verizon customers...

Read the Decision Summary
Decision

Following National Advertising Division Challenge, PetIQ Voluntarily Discontinues Certain Claims for NextStar Flea & Tick Topical

New York, NY – November 6, 2024 – Following a National Advertising Division challenge, PetIQ discontinued certain claims for its NextStar Flea & Tick topical flea prevention and treatment product, which appeared on PetIQ’s website, social media, and third-party websites.

Read the Decision Summary
Decision

National Advertising Division Finds Certain Safety Claims for Drunk Elephant Skincare Products Supported; Recommends Modification of Influencer Posts

New York, NY – November 4, 2024 – The National Advertising Division determined certain Drunk Elephant social media claims regarding skincare products being “safe for kids and tweens to use” were supported, but determined that two TikTok video influencer disclosures for Drunk Elephant's B-Goldi...

Read the Decision Summary